Expression, purification, and human antibody response to a 67 kDa vaccine candidate for schistosomiasis japonica

Julie S. Solomon, Christian P. Nixon, Stephen T. McGarvey, Luz P. Acosta, Daria Manalo, Jonathan D. Kurtis

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Schistosomiasis remains a leading cause of morbidity and mortality in the developing tropical world, and vaccines to prevent these infections remain a scientific and public health priority. Sj67 is a 67kDa Schistosoma japonicum surface membrane protein homologous to a family of actin-binding proteins. Sj67 is recognized by a mouse monoclonal antibody (mAb 6) that confers resistance to challenge infection in passive transfer experiments. These data support Sj67 as a potential vaccine candidate for schistosomiasis japonica. In the present study, we report the ligation-independent cloning of a cDNA encoding thioredoxin/elastin-like polypeptide (ELP)/rSj67 into a pET-32 Xa/LIC vector. Soluble recombinant fusion protein (Thio-ELP-rSj67) was expressed and purified using anion-exchange and size exclusion chromatography. rSj67 was cleaved from the Thio-ELP fusion partner by digestion with Factor Xa protease and purified using hydroxyapatite column chromatography. Endotoxin was reduced by absorption to a polymyxin support. Purified rSj67 had a molecular weight of 67kDa and N-terminal sequencing confirmed that the first five amino acids of the recombinant protein matched the predicted sequence for the Sj67 gene. In Western blot analysis, rSj67 was recognized by the Sj67 specific mAb 6 antibody. IgG antibodies in sera from schistosomiasis infected volunteers living in an endemic area of the Philippines (n=13) recognized rSj67 with 4.7-fold greater median fluorescence compared to uninfected North American controls (n=5) (p<0.009). Together, these data confirm the expression and purification of recombinant Sj67 and its immuno-reactivity with sera from S. japonicum infected humans.

Original languageEnglish (US)
Pages (from-to)226-231
Number of pages6
JournalProtein Expression and Purification
Volume36
Issue number2
DOIs
StatePublished - Aug 2004
Externally publishedYes

Fingerprint

Schistosomiasis japonica
Elastin
Antibody Formation
Schistosoma japonicum
Purification
Vaccines
Schistosomiasis
Peptides
Antibodies
Membrane Proteins
Polymyxins
Recombinant Fusion Proteins
Health Priorities
Microfilament Proteins
Column chromatography
Thioredoxins
Factor Xa
Philippines
Size exclusion chromatography
Cloning

Keywords

  • ELP
  • Schistosomiasis
  • Vaccine

ASJC Scopus subject areas

  • Biochemistry

Cite this

Expression, purification, and human antibody response to a 67 kDa vaccine candidate for schistosomiasis japonica. / Solomon, Julie S.; Nixon, Christian P.; McGarvey, Stephen T.; Acosta, Luz P.; Manalo, Daria; Kurtis, Jonathan D.

In: Protein Expression and Purification, Vol. 36, No. 2, 08.2004, p. 226-231.

Research output: Contribution to journalArticle

Solomon, Julie S. ; Nixon, Christian P. ; McGarvey, Stephen T. ; Acosta, Luz P. ; Manalo, Daria ; Kurtis, Jonathan D. / Expression, purification, and human antibody response to a 67 kDa vaccine candidate for schistosomiasis japonica. In: Protein Expression and Purification. 2004 ; Vol. 36, No. 2. pp. 226-231.
@article{0117bf78cdef48aea7393cc67b547c88,
title = "Expression, purification, and human antibody response to a 67 kDa vaccine candidate for schistosomiasis japonica",
abstract = "Schistosomiasis remains a leading cause of morbidity and mortality in the developing tropical world, and vaccines to prevent these infections remain a scientific and public health priority. Sj67 is a 67kDa Schistosoma japonicum surface membrane protein homologous to a family of actin-binding proteins. Sj67 is recognized by a mouse monoclonal antibody (mAb 6) that confers resistance to challenge infection in passive transfer experiments. These data support Sj67 as a potential vaccine candidate for schistosomiasis japonica. In the present study, we report the ligation-independent cloning of a cDNA encoding thioredoxin/elastin-like polypeptide (ELP)/rSj67 into a pET-32 Xa/LIC vector. Soluble recombinant fusion protein (Thio-ELP-rSj67) was expressed and purified using anion-exchange and size exclusion chromatography. rSj67 was cleaved from the Thio-ELP fusion partner by digestion with Factor Xa protease and purified using hydroxyapatite column chromatography. Endotoxin was reduced by absorption to a polymyxin support. Purified rSj67 had a molecular weight of 67kDa and N-terminal sequencing confirmed that the first five amino acids of the recombinant protein matched the predicted sequence for the Sj67 gene. In Western blot analysis, rSj67 was recognized by the Sj67 specific mAb 6 antibody. IgG antibodies in sera from schistosomiasis infected volunteers living in an endemic area of the Philippines (n=13) recognized rSj67 with 4.7-fold greater median fluorescence compared to uninfected North American controls (n=5) (p<0.009). Together, these data confirm the expression and purification of recombinant Sj67 and its immuno-reactivity with sera from S. japonicum infected humans.",
keywords = "ELP, Schistosomiasis, Vaccine",
author = "Solomon, {Julie S.} and Nixon, {Christian P.} and McGarvey, {Stephen T.} and Acosta, {Luz P.} and Daria Manalo and Kurtis, {Jonathan D.}",
year = "2004",
month = "8",
doi = "10.1016/j.pep.2004.04.011",
language = "English (US)",
volume = "36",
pages = "226--231",
journal = "Protein Expression and Purification",
issn = "1046-5928",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Expression, purification, and human antibody response to a 67 kDa vaccine candidate for schistosomiasis japonica

AU - Solomon, Julie S.

AU - Nixon, Christian P.

AU - McGarvey, Stephen T.

AU - Acosta, Luz P.

AU - Manalo, Daria

AU - Kurtis, Jonathan D.

PY - 2004/8

Y1 - 2004/8

N2 - Schistosomiasis remains a leading cause of morbidity and mortality in the developing tropical world, and vaccines to prevent these infections remain a scientific and public health priority. Sj67 is a 67kDa Schistosoma japonicum surface membrane protein homologous to a family of actin-binding proteins. Sj67 is recognized by a mouse monoclonal antibody (mAb 6) that confers resistance to challenge infection in passive transfer experiments. These data support Sj67 as a potential vaccine candidate for schistosomiasis japonica. In the present study, we report the ligation-independent cloning of a cDNA encoding thioredoxin/elastin-like polypeptide (ELP)/rSj67 into a pET-32 Xa/LIC vector. Soluble recombinant fusion protein (Thio-ELP-rSj67) was expressed and purified using anion-exchange and size exclusion chromatography. rSj67 was cleaved from the Thio-ELP fusion partner by digestion with Factor Xa protease and purified using hydroxyapatite column chromatography. Endotoxin was reduced by absorption to a polymyxin support. Purified rSj67 had a molecular weight of 67kDa and N-terminal sequencing confirmed that the first five amino acids of the recombinant protein matched the predicted sequence for the Sj67 gene. In Western blot analysis, rSj67 was recognized by the Sj67 specific mAb 6 antibody. IgG antibodies in sera from schistosomiasis infected volunteers living in an endemic area of the Philippines (n=13) recognized rSj67 with 4.7-fold greater median fluorescence compared to uninfected North American controls (n=5) (p<0.009). Together, these data confirm the expression and purification of recombinant Sj67 and its immuno-reactivity with sera from S. japonicum infected humans.

AB - Schistosomiasis remains a leading cause of morbidity and mortality in the developing tropical world, and vaccines to prevent these infections remain a scientific and public health priority. Sj67 is a 67kDa Schistosoma japonicum surface membrane protein homologous to a family of actin-binding proteins. Sj67 is recognized by a mouse monoclonal antibody (mAb 6) that confers resistance to challenge infection in passive transfer experiments. These data support Sj67 as a potential vaccine candidate for schistosomiasis japonica. In the present study, we report the ligation-independent cloning of a cDNA encoding thioredoxin/elastin-like polypeptide (ELP)/rSj67 into a pET-32 Xa/LIC vector. Soluble recombinant fusion protein (Thio-ELP-rSj67) was expressed and purified using anion-exchange and size exclusion chromatography. rSj67 was cleaved from the Thio-ELP fusion partner by digestion with Factor Xa protease and purified using hydroxyapatite column chromatography. Endotoxin was reduced by absorption to a polymyxin support. Purified rSj67 had a molecular weight of 67kDa and N-terminal sequencing confirmed that the first five amino acids of the recombinant protein matched the predicted sequence for the Sj67 gene. In Western blot analysis, rSj67 was recognized by the Sj67 specific mAb 6 antibody. IgG antibodies in sera from schistosomiasis infected volunteers living in an endemic area of the Philippines (n=13) recognized rSj67 with 4.7-fold greater median fluorescence compared to uninfected North American controls (n=5) (p<0.009). Together, these data confirm the expression and purification of recombinant Sj67 and its immuno-reactivity with sera from S. japonicum infected humans.

KW - ELP

KW - Schistosomiasis

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=3142571481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142571481&partnerID=8YFLogxK

U2 - 10.1016/j.pep.2004.04.011

DO - 10.1016/j.pep.2004.04.011

M3 - Article

VL - 36

SP - 226

EP - 231

JO - Protein Expression and Purification

JF - Protein Expression and Purification

SN - 1046-5928

IS - 2

ER -